In consultation: Guidance and quality standards
Showing 1 to 1 of 1
Title | Consultation | Type | Consultation end date |
---|---|---|---|
Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer [ID6339] | Draft guidance | Technology appraisal guidance |